Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized Trial

Cheng P.-N.CHUN-JEN LIUChen C.-Y.Tseng K.-C.Lo C.-C.Peng C.-Y.Lin C.-L.Chiu H.-C.Chiu Y.-C.PEI-JER CHEN2022-01-242022-01-2420221542-3565https://www.scopus.com/inward/record.uri?eid=2-s2.0-85122960193&doi=10.1016%2fj.cgh.2021.11.032&partnerID=40&md5=a10049a99ad9741dfffff4e9b1c941b9https://scholars.lib.ntu.edu.tw/handle/123456789/592978[SDGs]SDG3Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized Trialjournal article10.1016/j.cgh.2021.11.032348641582-s2.0-85122960193